Bevacizumab Plus Nab-paclitaxel and Platinum for Immunotherapy-treated Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT05407155 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05407155
- Sponsor
- Fudan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-09
- Primary completion
- 2026-04-15
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.